Edinburgh, UK
Queen Mary University London, London, UK
Tue 09 15:25
OC4.2
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
Queen Mary University London, London, UK
MRC Laboratory of Medical Sciences, London, UK
Tue 09 12:00
S3.2
Advances in diagnostics for ACC-a multiomics approach
MRC Laboratory of Medical Sciences, London, UK
Tue 09 12:30
S3.3
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
Unknown speaker
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
Mayo Clinic, Minnesota, USA
Wed 10 11:35
S6.3
CT characteristics of adrenal nodules to guide management
Mayo Clinic, Minnesota, USA
University College London, London, UK
Tue 09 12:30
S1.3
A new era in gut-hormone based pharmacotherapy for people with obesity?
University College London, London, UK
Imperial College London, London, UK
Wed 10 14:10
Hormones, Cancer and COVID - headlines from 2020-21
Imperial College London, London, UK
King's College London, London, UK
Tue 09 17:40
BPW2.2
Ready Player One? 3D Gut endocrinology in a dish
King's College London, London, UK
University of Birmingham, Birmingham, UK
Tue 09 13:05
MTE3
Thyroid disease assessment and management; controversies in the NICE guidelines
University of Birmingham, Birmingham, UK
Wed 10 09:35
FOE1.1
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Wed 10 14:20
Summary of the NIHR assessment of RFA in thyroid nodules
University of Birmingham, Birmingham, UK
Memorial Sloane Kettering Cancer center, New York, USA
Wed 10 12:10
MTE4
Thyroid surveillance after radiotherapy
Memorial Sloane Kettering Cancer center, New York, USA
University of Leeds, Leeds, UK
Guy's and St Thomas' Hospital, London, UK
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Mon 08 11:50
HDI1.4
How do I screen an SDH gene carrier?
Unknown speaker
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Wed 10 14:10
A survey on the management of metastatic PPGL in UK & Ireland
Unknown speaker
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Imperial College London, London, United Kingdom
Mon 08 09:45
WIN1
What is New in Basic Endocrinology Research?
Imperial College London, London, United Kingdom
University of Utah, Utah, USA
Queen Mary University of London, London, UK
Mon 08 16:20
OC2.6
Transcriptomic analysis of succinate dehydrogenase subunit deleted cells to identify molecular mechanisms underlying the increased metastatic potential of SDHB-deficient tumours
Queen Mary University of London, London, UK
Christie Hospital NHS Foundation Trust, Manchester, UK
Wed 10 13:38
OP6.2
The evaluation of a musculoskeletal health package intervention to prevent bone toxicity in women with gynaecological malignancies undergoing pelvic radiotherapy. The RadBone randomised controlled feasibility study.
Christie Hospital NHS Foundation Trust, Manchester, UK
Dresden University of Technology, Dresden, Germany
Mon 08 12:05
BPW1.3
What you need to know about immunometabolism
Dresden University of Technology, Dresden, Germany
Newcastle, UK
Tue 09 15:10
OC6.1
Imperial College London, London, UK
Wed 10 13:46
OP6.3
An unusual presentation of hypoglycaemia: An investigative challenge
Imperial College London, London, UK
Imperial College Healthcare NHS Trust, London, UK
Mon 08 13:01
OP1.3
Thyroid Endocrine Nurse Service: Improving patient experience
Imperial College Healthcare NHS Trust, London, UK
University of Edinburgh, Edinburgh, UK
Mon 08 15:05
OC3.1
The serotonin transporter SLC6A4 protects human brown adipose tissue from serotonin-mediated suppression of thermogenesis
University of Edinburgh, Edinburgh, UK
National Institute of Dental and Craniofacial Research, Bethesda MD, USA
Wed 10 11:35
S5.3
Targeting the Calcium-Sensing Receptor
National Institute of Dental and Craniofacial Research, Bethesda MD, USA
Université de Genève, Brussels, Belgium
Tue 09 18:10
BPW2.3
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.2
Management of adrenal insufficiency
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.5
Management of calcium disorders and osteoporosis
University Hospitals Birmingham, Birmingham, UK
St Vincent's University Hospital, Dublin, Ireland
Tue 09 17:10
HDI2.1
How do I investigate abnormal alkaline phosphatase and bone context?
St Vincent's University Hospital, Dublin, Ireland
John Radcliffe Hospital, Oxford, UK
Royal Victoria Hospital, Belfast, UK
Tue 09 16:25
OC6.6
Forty years' experience of national screening programme for congenital hypothyroidism in Northern Ireland.
Queen's University Belfast, Belfast, UK
Royal Victoria Hospital, Belfast, UK
London South Bank University, London, UK
Tue 09 16:15
NS2.4
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
University of Exeter, Exeter, UK
Tue 09 09:35
EC1.1
Early Career Prize Lecture Basic Science: Using gene discovery to identify new key regulators of beta cell development
University of Exeter, Exeter, UK
Oslo University Hospital, Oslo, Norway
Wed 10 15:40
Blood doping: climbing to the peak of athletic performance
Oslo University Hospital, Oslo, Norway
London, UK
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Mon 08 13:28
OP2.2
Single-centre analysis of 900 short synacthen tests: do pre-test clinical or biochemical variables predict failure?
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
St Bartholomew’s Hospital, London, UK
Tue 09 11:00
OCP1.1
Improving the care of patients with thyroid diseases
St Bartholomew’s Hospital, London, UK
Barts Health NHS Trust, London, UK
Mon 08 10:00
WIN2
Nottingham Trent University, Nottingham, UK
Tue 09 14:46
OP4.3
The Chemerin-CMKLR1 Axis is Functionally Important for Central Regulation of Energy Homeostasis
Nottingham Trent University, Nottingham, UK
University of Sheffield, Sheffield, UK
Wed 10 12:55
OP5.1
Parathyroid hormone (PTH) of 1.6 pmol/L or more at 6 months is associated with delayed recovery of parathyroid function in post-surgical hypoparathyroidism (PoSH)
University of Sheffield, Sheffield, UK
MRC Institute of Metabolic Science, Cambridge, UK
Monash University, Melbourne, Australia
Tue 09 09:00
PL5
Activation of the gp130 receptor: a panacea for the treatment of metabolic diseases?
Monash University, Melbourne, Australia
The Royal Wolverhampton NHS Trust, Wolverhampton, UK
Wed 10 13:19
OP5.4
Normocalcaemic hyperparathyroidism: Impact of assay and reference range differences on the diagnosis
The Royal Wolverhampton NHS Trust, Wolverhampton, UK
Imperial College London, London, UK
Mon 08 16:05
OC2.5
A novel MiR-346-directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer
Imperial College London, London, UK
Tue 09 12:30
S3.3
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
Unknown speaker
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
The University of Edinburgh, Edinburgh, UK
Queen Elizabeth University Hospital, Glasgow, UK
Tue 09 18:10
HDI2.5
How do I confirm biochemical diagnosis of primary aldosteronism?
Queen Elizabeth University Hospital, Glasgow, UK
Rockefeller University, New York, USA
Mon 08 10:15
AN1
Discovery of a new hormone, leptin, and its roles in health and disease
Rockefeller University, New York, USA
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Wed 10 13:30
OP6.1
Incidental findings are common, but rarely clinically significant, in patients with Neuroendocrine Tumours undergoing Gallium68 Dotatate PET CT; results from a one year retrospective review
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
University College London Hospital, London, UK
Tue 09 17:55
HDI2.4
How do I screen for cardiovascular effects of cancer treatments?
University College London Hospital, London, UK
University of Edinburgh, Edinburgh, UK
Wed 10 14:10
An overview of thyroid papers
University of Edinburgh, Edinburgh, UK
Unknown speaker
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
University of Birmingham, Birmingham, UK
Wed 10 15:05
ECS1.2
Post-doc to Research Facilitator; making the transition
University of Birmingham, Birmingham, UK
University Hospitals Birmingham, Birmingham, UK
Wed 10 15:20
Influencing at scale: NHS leadership and shaping policy
University Hospitals Birmingham, Birmingham, UK
University of Oxford, Oxford, UK
Tue 09 16:10
OC5.5
Diacylglycerol kinase delta haploinsufficiency in mice causes hypocalcaemia: relevance to human Autosomal Dominant Hypoclacemia (ADH)
University of Oxford, Oxford, UK
University of Birmingham, Birmingham, UK
Wed 10 14:10
Updates and future plans for the Bone and Calcium network
Norfolk and Norwich University Hospital, Norfolk, UK
University of Birmingham, Birmingham, UK
Association for Multiple Endocrine Neoplasia Disorders, Southborough, UK
Tue 09 12:30
NS1.3
Addressing the unmet psychosocial needs of patients with treated Acromegaly
Association for Multiple Endocrine Neoplasia Disorders, Southborough, UK
Green Templeton College, University of Oxford, London, UK
Tue 09 11:30
NS1.1
Advances in the management of Acromegaly 2021
Green Templeton College, University of Oxford, London, UK
University of Birmingham, Birmingham, UK
Mon 08 16:05
OC1.5
Is radiotherapy for pituitary adenoma or craniopharyngioma associated with increased risk of second brain tumour? A long-term multi-centre study of 3,679 patients
University of Birmingham, Birmingham, UK
University of Michigan, Michigan, USA
Odense University Hospital, Odense, Denmark
Tue 09 15:25
OC5.2
Gastric inhibitory polypeptide (GIP) reduces human osteoclast activity by suppressing multiple signalling pathways
Odense University Hospital, Odense, Denmark
Mayo Clinic, Rochester, MN, USA
Tue 09 15:40
OC6.3
Failure of Radioiodine Remnant Ablation to Improve Postoperative Outcome in 2668 Adult Patients with AJCC/pTNM stage I Papillary Thyroid Carcinoma
Mayo Clinic, Rochester, MN, USA
University of Aberdeen, Aberdeen, UK
Essen, Germany
Mon 08 14:00
PL1
The Christie NHS Foundation Trust, Manchester, UK
Mon 08 11:05
HDI1.1
How should I investigate for effect of radiotherapy on the hypothalamus and pituitary?
Unknown speaker
The Christie NHS Foundation Trust, Manchester, UK
University of Southampton, Southampton, UK
Newcastle University, Newcastle, UK
Tue 09 16:25
OC5.6
The role of vitamin D supplementation in critically ill patients with COVID-19
Newcastle University, Newcastle, UK
Imperial College London, London, UK
Homerton University Hospital, London, UK
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University Hospital of Wales, Cardiff, UK
University of Nottingham, Nottingham , UK
Tue 09 18:10
SE1.3
INSL3: a new index of testis function in puberty and aging
University of Nottingham, Nottingham , UK
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Wed 10 09:35
SK1.1
The Geneticist's Perspective
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
King's College London, London, UK
Mon 08 15:20
OC3.2
Comparing the transcriptional landscape between lean and obese mice within the small intestinal segments
King's College London, London, UK
Imperial College London, London, UK
Tue 09 11:00
TAA1
Teaching fertile minds- seeking out teaching opportunities during clinical training
Imperial College London, London, UK
Imperial College London, London, UK
Tue 09 08:00
ARG1.2
Changes to safety monitoring for androgen replacement in men
Imperial College London, London, UK
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
Tue 09 15:40
OC5.3
Role of Intact and C-Terminal FGF-23 Assays in the Investigation of Metabolic Bone Disease.
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
King's College London, London, UK
Mon 08 16:20
OC1.6
Differential follicle stimulating hormone glycosylation modulates pre-antral follicle growth and survival rates
Unknown speaker
King's College London, London, UK
Johannes Gutenberg University Medical Center, Mianz, Germany
Medical University of Gdansk, Gdansk, Poland
Tue 09 13:55
OP3.1
Discordant growth hormone and insulin like growth factor-1 values are associated with an increased mortality over concordant normal values in patients treated for acromegaly
Medical University of Gdansk, Gdansk, Poland
Birmingham, UK
Queen's University Belfast, Belfast, UK
Tue 09 16:25
OC6.6
Forty years' experience of national screening programme for congenital hypothyroidism in Northern Ireland.
Queen's University Belfast, Belfast, UK
Royal Victoria Hospital, Belfast, UK
Salford Royal NHS Foundation Trust, Salford, UK
Tue 09 16:15
NS2.4
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
University of Birmingham Institute of Metabolism and System Research, Birmingham, UK
Mon 08 15:50
OC2.4
PBF phosphorylation regulates cell motility of thyroid and breast cancer cells
University of Birmingham Institute of Metabolism and System Research, Birmingham, UK
University of Oxford, Oxford, UK
National Institute of Environmental Health Sciences, Durham, USA
Tue 09 17:40
SE1.2
What in the World is EIS?
National Institute of Environmental Health Sciences, Durham, USA
London, London, UK
Centre for Cardiovascular Science, Edinburgh, United Kingdom
Tue 09 16:25
OC4.6
Glucocorticoids and the Vascular Molecular Clock : Implications in Vascular Function Control
Centre for Cardiovascular Science, Edinburgh, United Kingdom
University College London Hospitals NHS Foundation Trust, London, UK
Mon 08 15:05
OC2.1
Outcomes of surgery and treatment with selective RET TK inhibitor Selpercatinib in children with MEN2 and advanced MTC.
Unknown speaker
University College London Hospitals NHS Foundation Trust, London, UK
Homerton University Hospital, London, UK
Wed 10 10:00
FOE1.4
The Society for Endocrinology Resource Hub
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Diurnal Ltd, Cardiff, United Kingdom
Tue 09 10:15
EC1.3
CET Best Clinical Abstract: Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia
Diurnal Ltd, Cardiff, United Kingdom
Diurnal Ltd, Sheffield, UK
University of Oxford, Oxford, UK
Tue 09 12:30
S3.3
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
Unknown speaker
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
University of Oxford Hospitals, Oxford, UK
Tue 09 15:30
NS2.2
Graduate Experience – Masters Module in Endocrine Nursing
University of Oxford Hospitals, Oxford, UK
Tue 09 16:15
NS2.4
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Imperial College London, London, UK
Mon 08 15:35
OC2.3
A novel in vivo platform for studying tumour vascularization and endocrine responses
Imperial College London, London, UK
University of Cambridge and Cambridge University Hospitals, Cambridge, UK
Tue 09 14:11
OP3.3
‘Suppression imaging’ – a novel PET technique for increasing confidence in the localisation of secretory pituitary microadenomas
University of Cambridge and Cambridge University Hospitals, Cambridge, UK
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Tue 09 11:15
NKM1
Nikki Kieffer Medal
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Tue 09 16:15
NS2.4
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Imperial College London, London, UK
Tue 09 11:15
TAA2
Nippon Medical School, Tokyo, Japan
Tue 09 15:10
OC5.1
Successful adeno-associated virus mediated neonatal gene therapy treatment of hypophosphatasia murine model resulted in bone maturation and increased survival to at least 18 months
Nippon Medical School, Tokyo, Japan
The University of Edinburgh, Edinburgh, UK
Wed 10 14:50
CMW2.1
Endometrial health - the role of the specialist menstrual disorders service
The University of Edinburgh, Edinburgh, UK
University of Duisburg-Essen, Essen, Germany
Tue 09 15:25
OC6.2
Concerted action of TH transporters MCT8 and OATP1C1 regulates adult hippocampal neurogenesis and hippocampal function in mice
University of Duisburg-Essen, Essen, Germany
Garvan Institute of Medical Research, Sydney, Australia
Wed 10 10:35
S5.1
Osteomorphs: a newcell entity regulating bone resorption
Garvan Institute of Medical Research, Sydney, Australia
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Mon 08 15:35
OC3.3
Sex-specific risk of obesity and cardiometabolic disease in low- and middle-income countries (LMICs): a meta-analysis in 681929 individuals
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Wellcome Trust, Cambridge, UK
Mon 08 16:20
OC3.6
Stimulation of motilin secretion by bile, free fatty acids and acidification in human duodenal organoids
Wellcome Trust, Cambridge, UK
The Christie NHS Foundation Trust, Manchester, UK
Wed 10 13:54
OP6.4
Virtual Blood Pressure Monitoring in the Pre-operative Management of Phaeochromocytoma Patients in a Tertiary Centre during the COVID-19 Pandemic
The Christie NHS Foundation Trust, Manchester, UK
Imperial College London, London, UK
Mon 08 15:50
OC1.4
Intranasal kisspeptin administration stimulates reproductive hormone secretion in healthy men
Imperial College London, London, UK
Queen Mary University of London, London, UK
Mon 08 15:35
OC1.3
Acromegalic cardiomyopathy in pituitary-specific aryl hydrocarbon receptor interacting protein (Aip) gene knockout animals
Unknown speaker
Queen Mary University of London, London, UK
University of California, California, USA
Tue 09 08:30
PL4
Feast and famine: nuclear receptor control of liver energy balance
University of California, California, USA
Beacon Hospital and University College Dublin, Dublin, Ireland
Tue 09 18:25
HDI2.6
How do I approach isolated hypothyroxinaemia?
Beacon Hospital and University College Dublin, Dublin, Ireland
Imperial College London, London, UK
University of Newcastle, Newcastle, UK
Wed 10 13:11
OP5.3
Vitamin D deficiency is highly prevalent among patients who died from COVID-19 in the North-East of England.
University of Newcastle, Newcastle, UK
University of Sheffield, Sheffield, UK
Wed 10 09:35
FOE1.1
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Wed 10 14:15
How to follow-up a patient with with Cushing's and remission after surgery
University of Sheffield, Sheffield, UK
University of Dundee, Dundee, United Kingdom
University of Pretoria, Pretoria, South Africa
Imperial College London, London, UK
Tue 09 10:25
EC1.4
CET Best Basic Abstract: The vagal calcium sensing receptor mediates the effect of protein ingestion on insulin release and regulates macronutrient metabolism
Imperial College London, London, UK
Oxford, UK
Imperial College, London, UK
Wed 10 15:50
Newcastle University, Newcastle, UK
Northern General Hospital, Sheffield, UK
University of Pittsburgh, Pittsburgh, USA
Guy's and St. Thomas' NHS Foundation Trust, London, UK
Tue 09 13:05
MTE7.2
How adolescent care is different to adults or children
Guy's and St. Thomas' NHS Foundation Trust, London, UK
Imperial College London, London, UK
Mon 08 16:05
OC3.5
Microbial tryptophan metabolites modulate L-cell-induced GLP-1 secretion to improve glucose homeostasis
Imperial College London, London, UK
United Lincolnshire Hospitals NHS Trust, Lincoln, UK
Mon 08 13:09
OP1.4
Autoimmune thyrotoxicosis: is first line treatment with anti-thyroid medication good enough?
United Lincolnshire Hospitals NHS Trust, Lincoln, UK
Harvard Medical School, Boston, USA
University of Birmingham, Birmingham, UK
Tue 09 09:55
EC1.2
Early Career Prize Lecture Clinical: Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study
University of Birmingham, Birmingham, UK
Imperial College London, London, UK
Tue 09 07:40
ARG1.1
Androgen replacement in men: Classification, diagnosis and biochemical assessment
Imperial College London, London, UK
Tue 09 17:25
HDI2.2
How do I diagnose and manage a low testosterone in men with obesity?
Imperial College London, London, UK
Queen Mary University of London, London, UK
Mon 08 15:20
OC1.2
Hyper-phosphorylation of β-catenin at Serine552 correlates with invasion and predicts recurrence of non-functioning pituitary tumours (NFPTs)
Queen Mary University of London, London, UK
Nuffield Department of Medicine, Oxford, UK
Mon 08 17:00
PR1
Elucidation of cellular oxygen sensing mechanisms: implications for medicine
Nuffield Department of Medicine, Oxford, UK
University of Birmingham, Birmingham, UK
Mon 08 15:20
OC2.2
An emerging role for proteostasis modulators targeting NIS activity to enhance radioiodide therapy in thyroid cancer
University of Birmingham, Birmingham, UK
Munich, Germany
The University of Edinburgh, Edinburgh, UK
Tue 09 17:40
HDI2.3
How do I manage pituitary macroadenoma in pregnancy?
The University of Edinburgh, Edinburgh, UK
Leighton Hospital, Cheshire, UK
Wed 10 09:40
FOE1.2
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 09:40
FOE1.2
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Leighton Hospital, Cheshire, UK
Wed 10 09:40
FOE1.2
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 09:40
FOE1.2
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, United Kingdom
Wed 10 10:35
S6.1
Single cell sequencing: lessons for the pathogenesis of adrenocortical tumours
Unknown speaker
University of Birmingham, Birmingham, United Kingdom
Diurnal Ltd, Sheffield, UK
Tue 09 10:15
EC1.3
CET Best Clinical Abstract: Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia
Diurnal Ltd, Cardiff, United Kingdom
Diurnal Ltd, Sheffield, UK
Imperial College London, London, UK
Tue 09 14:54
OP4.4
Audit of Clinical Outcomes with Dexamethasone in Patients Hospitalised with COVID-19
Imperial College London, London, UK
King's College London, London, UK
Tue 09 17:10
BPW2.1
Modelling diabetes using iPSCs and adult derived organoids
King's College London, London, UK
University College London, London, UK
Tue 09 15:10
OC4.1
Development of [18F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of patients with Primary Hyperaldosteronism.
University College London, London, UK
Cardiff University, Cardiff, UK
Tue 09 16:10
OC6.5
Effects of in utero thyroid hormone exposure on human neurodevelopment: MRI analysis from the Controlled Antenatal Thyroid Screening Study
Cardiff University, Cardiff, UK
St George's Hospital, London, UK
Wed 10 15:15
CMW2.2
Optimising health outcomes following gender reassignment
St George's Hospital, London, UK
University of Cambridge, Cambridge, UK
Mon 08 13:20
OP2.1
A phase 1 clinical trial evaluating the safety and efficacy of up to two administrations of the adrenal PET tracer [18F]CETO in healthy volunteers and patients with primary aldosteronism
University of Cambridge, Cambridge, UK
Tue 09 15:40
OC4.3
[11C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism
University of Cambridge, Cambridge, UK
Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
Mon 08 11:05
BPW1.1
Applying cryo-EM to understanding the structure and dynamics of GPCRs
Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
Swansea Bay University Health Board, Swansea, UK
Mon 08 12:53
OP1.2
Long-term management of thyrotoxicosis with anti-thyroid drugs (ATDs)
Swansea Bay University Health Board, Swansea, UK
The Christie NHS Foundation Trust, Manchester, UK
Wed 10 16:40
PL10
Cancer Treatment Endocrinopathies and growth hormone status throughout life
The Christie NHS Foundation Trust, Manchester, UK
University of Oxford, Oxford, UK
Tue 09 11:30
S3.1
Diagnosis and management of MEN1 in childhood and adolescence
University of Oxford, Oxford, UK
Tue 09 12:30
S3.3
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
Unknown speaker
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
Norfolk and Norwich University Hospital, Norwich, UK
Wed 10 13:03
OP5.2
Society for Endocrinology / Parathyroid UK National Hypoparathyroidism Management Audit
Norfolk and Norwich University Hospital, Norwich, UK
University of Birmingham, Birmingham, UK
Tue 09 16:15
NS2.4
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
University College London Hospital, London, UK
Mon 08 12:05
HDI1.5
How do I keep my patients with adrenal insufficiency safe?
University College London Hospital, London, UK
Tue 09 11:15
OCP1.2
Patient safety - Shifting the paradigm
University College London Hospital, London, UK
Tue 09 17:10
NS3.1
Management of Hyponatraemia and Diabetes Insipidus
University College London Hospital, London, UK
Tue 09 17:10
NS3.3
Management of hyper- and hypo-thyroidism
University College London Hospital, London, UK
University of Newcastle, New South Wales, Australia
Tue 09 12:30
S2.3
Rapid gene therapy targeting of nuclear receptor pathways in the testis
University of Newcastle, New South Wales, Australia
Institute of Metabolism and System Research, Birmingham, UK
Tue 09 16:10
OC4.5
Circulating cell-free DNA-based biomarkers as a tool for disease surveillance in adrenocortical carcinoma
Institute of Metabolism and System Research, Birmingham, UK
University of Derby, Derby, United Kingdom
Tue 09 14:38
OP4.2
3mg Liraglutide ameliorates inflammation and improves hypothalamic regulation of energy homeostasis by modulation of Sphingosine-1-Phosphate signalling in super-responders
University of Derby, Derby, United Kingdom
Imperial College London, London, UK
Tue 09 14:30
OP4.1
Investigating the role of the gut metabolome in appetite and obesity
Imperial College London, London, UK
University of Edinburgh, Edinburgh, UK
Mon 08 14:30
PL2
Strategies to turn up the heat - investigating human brown adipose tissue function
University of Edinburgh, Edinburgh, UK
University of Birmingham, Birmingham, UK
Wed 10 12:10
MTE6
Primary interventions in obesity and weight management
University of Birmingham, Birmingham, UK
Cardiff University, Cardiff, UK
Mon 08 12:45
OP1.1
Factors predicting long-term outcome and the need for surgery in Graves' Orbitopathy extended follow-up from the CIRTED Trial
Unknown speaker
Cardiff University, Cardiff, UK
Wed 10 14:10
An overview of thyroid papers
University of Edinburgh, Edinburgh, UK
Unknown speaker
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Newcastle University, Newcastle, UK
Cardiff University, Cardiff, UK
Mon 08 12:45
OP1.1
Factors predicting long-term outcome and the need for surgery in Graves' Orbitopathy extended follow-up from the CIRTED Trial
Unknown speaker
Cardiff University, Cardiff, UK
Wed 10 14:10
An overview of thyroid papers
University of Edinburgh, Edinburgh, UK
Unknown speaker
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Oxford, United Kingdom
University of Birmingham, Birmingham, UK
Tue 09 15:55
OC6.4
AP-2 and Moesin Regulate the Internalisation of the Sodium-Iodide Symporter and Affect I125 Uptake in Thyroid Cancer Cells.
University of Birmingham, Birmingham, UK
Imperial College London, London, UK
Mon 08 15:05
OC1.1
Melanocortin-4 receptor agonism improves sexual brain processing in women with low sexual desire
Imperial College London, London, UK
University of Oxford, Oxford, UK
Wed 10 16:10
PL9
Revisiting Cushing’s: The power of pre-receptor metabolism
University of Oxford, Oxford, UK
Norfolk and Norwich University Hospital, Norfolk, UK
Wed 10 14:10
Updates and future plans for the Bone and Calcium network
Norfolk and Norwich University Hospital, Norfolk, UK
University of Birmingham, Birmingham, UK
Coventry University, Coventry, UK
Wed 10 14:10
What skills, techniques and experience can you gain from visiting another laboratory
Coventry University, Coventry, UK
University of Bristol, Bristol, UK
Tue 09 15:55
OC4.4
24-hour dynamics of free tissue adrenal hormones: A description of healthy normal variation
University of Bristol, Bristol, UK
Leuven University, Leuven, Belgium
Tue 09 18:45
PL6
Rethinking critical illness-induced corticosteroid insufficiency
Leuven University, Leuven, Belgium
Erasmus Medical Center, Rotterdam, The Netherlands
Wed 10 11:35
S4.3
Translational Studies in Thyroid Hormone Transport
Erasmus Medical Center, Rotterdam, The Netherlands
GReD, Clermont-Ferrand, France
Tue 09 12:00
S2.2
Bile acid metabolism & nuclear receptors in male reproduction
GReD, Clermont-Ferrand, France
Sheffield, UK
Mon 08 11:20
HDI1.2
University of Duidburg-Essen, Essen, Germany
University of Edinburgh, Edinburgh, UK
Mon 08 15:50
OC3.4
Hepatic choline deficiency underpins amelioration of visceral obesity and diabetes in ectonucleotide pyrophosphatase (Enpp)-6–/–mice
University of Edinburgh, Edinburgh, UK
Institute of Metabolism and System Research, Birmingham, UK
Mon 08 13:36
OP2.3
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma
Institute of Metabolism and System Research, Birmingham, UK
King's College London, London, UK
Tue 09 14:19
OP3.4
Stem cell heterogeneity and regulation in the postnatal pituitary gland
King's College London, London, UK
University College London Hospital, London, UK
Mon 08 11:35
HDI1.3
University of Cambridge, Cambridge, UK
Mon 08 11:35
BPW1.2
SC analysis and heterogeneity of hypothalamic neurons
University of Cambridge, Cambridge, UK
The London Clinic, London, UK
Tue 09 13:05
MTE7.1
Hydrocortisone pump - Innovative practice across both NHS and Independent sector
The London Clinic, London, UK
Royal Infirmary of Edinburgh, Edinburgh, UK
Mon 08 12:20
HDI1.6
How do I optimise thyroid status after RAI therapy?
Royal Infirmary of Edinburgh, Edinburgh, UK
University of Birmingham, Birmingham, UK
Mon 08 13:44
OP2.4
Modelling changes in the control, secretion and metabolism of cortisol during and after heart surgery.
University of Birmingham, Birmingham, UK
Université Paris Cité, Paris , France
Wed 10 11:05
S6.2
Workshop
4
Oral
12
Expert
7
Plenary
11
Catering and Social
10
Nurse
3
Other
3
Symposium
5
No Session Type
35
Mon 08 11:05
BPW1.1
Applying cryo-EM to understanding the structure and dynamics of GPCRs
Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
Mon 08 11:35
BPW1.2
SC analysis and heterogeneity of hypothalamic neurons
University of Cambridge, Cambridge, UK
Mon 08 12:05
BPW1.3
What you need to know about immunometabolism
Dresden University of Technology, Dresden, Germany
Tue 09 17:10
BPW2.1
Modelling diabetes using iPSCs and adult derived organoids
King's College London, London, UK
Tue 09 17:40
BPW2.2
Ready Player One? 3D Gut endocrinology in a dish
King's College London, London, UK
Tue 09 18:10
BPW2.3
Wed 10 14:50
CMW2.1
Endometrial health - the role of the specialist menstrual disorders service
The University of Edinburgh, Edinburgh, UK
Wed 10 15:15
CMW2.2
Optimising health outcomes following gender reassignment
St George's Hospital, London, UK
Mon 08 12:45
OP1.1
Factors predicting long-term outcome and the need for surgery in Graves' Orbitopathy extended follow-up from the CIRTED Trial
Unknown speaker
Cardiff University, Cardiff, UK
Mon 08 12:53
OP1.2
Long-term management of thyrotoxicosis with anti-thyroid drugs (ATDs)
Swansea Bay University Health Board, Swansea, UK
Mon 08 13:01
OP1.3
Thyroid Endocrine Nurse Service: Improving patient experience
Imperial College Healthcare NHS Trust, London, UK
Mon 08 13:09
OP1.4
Autoimmune thyrotoxicosis: is first line treatment with anti-thyroid medication good enough?
United Lincolnshire Hospitals NHS Trust, Lincoln, UK
Mon 08 13:20
OP2.1
A phase 1 clinical trial evaluating the safety and efficacy of up to two administrations of the adrenal PET tracer [18F]CETO in healthy volunteers and patients with primary aldosteronism
University of Cambridge, Cambridge, UK
Mon 08 13:28
OP2.2
Single-centre analysis of 900 short synacthen tests: do pre-test clinical or biochemical variables predict failure?
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Mon 08 13:36
OP2.3
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma
Institute of Metabolism and System Research, Birmingham, UK
Mon 08 13:44
OP2.4
Modelling changes in the control, secretion and metabolism of cortisol during and after heart surgery.
University of Birmingham, Birmingham, UK
Mon 08 15:05
OC1.1
Melanocortin-4 receptor agonism improves sexual brain processing in women with low sexual desire
Imperial College London, London, UK
Mon 08 15:20
OC1.2
Hyper-phosphorylation of β-catenin at Serine552 correlates with invasion and predicts recurrence of non-functioning pituitary tumours (NFPTs)
Queen Mary University of London, London, UK
Mon 08 15:35
OC1.3
Acromegalic cardiomyopathy in pituitary-specific aryl hydrocarbon receptor interacting protein (Aip) gene knockout animals
Unknown speaker
Queen Mary University of London, London, UK
Mon 08 15:50
OC1.4
Intranasal kisspeptin administration stimulates reproductive hormone secretion in healthy men
Imperial College London, London, UK
Mon 08 16:05
OC1.5
Is radiotherapy for pituitary adenoma or craniopharyngioma associated with increased risk of second brain tumour? A long-term multi-centre study of 3,679 patients
University of Birmingham, Birmingham, UK
Mon 08 16:20
OC1.6
Differential follicle stimulating hormone glycosylation modulates pre-antral follicle growth and survival rates
Unknown speaker
King's College London, London, UK
Mon 08 15:05
OC2.1
Outcomes of surgery and treatment with selective RET TK inhibitor Selpercatinib in children with MEN2 and advanced MTC.
Unknown speaker
University College London Hospitals NHS Foundation Trust, London, UK
Mon 08 15:20
OC2.2
An emerging role for proteostasis modulators targeting NIS activity to enhance radioiodide therapy in thyroid cancer
University of Birmingham, Birmingham, UK
Mon 08 15:35
OC2.3
A novel in vivo platform for studying tumour vascularization and endocrine responses
Imperial College London, London, UK
Mon 08 15:50
OC2.4
PBF phosphorylation regulates cell motility of thyroid and breast cancer cells
University of Birmingham Institute of Metabolism and System Research, Birmingham, UK
Mon 08 16:05
OC2.5
A novel MiR-346-directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer
Imperial College London, London, UK
Mon 08 16:20
OC2.6
Transcriptomic analysis of succinate dehydrogenase subunit deleted cells to identify molecular mechanisms underlying the increased metastatic potential of SDHB-deficient tumours
Queen Mary University of London, London, UK
Mon 08 15:05
OC3.1
The serotonin transporter SLC6A4 protects human brown adipose tissue from serotonin-mediated suppression of thermogenesis
University of Edinburgh, Edinburgh, UK
Mon 08 15:20
OC3.2
Comparing the transcriptional landscape between lean and obese mice within the small intestinal segments
King's College London, London, UK
Mon 08 15:35
OC3.3
Sex-specific risk of obesity and cardiometabolic disease in low- and middle-income countries (LMICs): a meta-analysis in 681929 individuals
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Mon 08 15:50
OC3.4
Hepatic choline deficiency underpins amelioration of visceral obesity and diabetes in ectonucleotide pyrophosphatase (Enpp)-6–/–mice
University of Edinburgh, Edinburgh, UK
Mon 08 16:05
OC3.5
Microbial tryptophan metabolites modulate L-cell-induced GLP-1 secretion to improve glucose homeostasis
Imperial College London, London, UK
Mon 08 16:20
OC3.6
Stimulation of motilin secretion by bile, free fatty acids and acidification in human duodenal organoids
Wellcome Trust, Cambridge, UK
Tue 09 13:55
OP3.1
Discordant growth hormone and insulin like growth factor-1 values are associated with an increased mortality over concordant normal values in patients treated for acromegaly
Medical University of Gdansk, Gdansk, Poland
Tue 09 14:11
OP3.3
‘Suppression imaging’ – a novel PET technique for increasing confidence in the localisation of secretory pituitary microadenomas
University of Cambridge and Cambridge University Hospitals, Cambridge, UK
Tue 09 14:19
OP3.4
Stem cell heterogeneity and regulation in the postnatal pituitary gland
King's College London, London, UK
Tue 09 14:30
OP4.1
Investigating the role of the gut metabolome in appetite and obesity
Imperial College London, London, UK
Tue 09 14:38
OP4.2
3mg Liraglutide ameliorates inflammation and improves hypothalamic regulation of energy homeostasis by modulation of Sphingosine-1-Phosphate signalling in super-responders
University of Derby, Derby, United Kingdom
Tue 09 14:46
OP4.3
The Chemerin-CMKLR1 Axis is Functionally Important for Central Regulation of Energy Homeostasis
Nottingham Trent University, Nottingham, UK
Tue 09 14:54
OP4.4
Audit of Clinical Outcomes with Dexamethasone in Patients Hospitalised with COVID-19
Imperial College London, London, UK
Tue 09 15:10
OC4.1
Development of [18F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of patients with Primary Hyperaldosteronism.
University College London, London, UK
Tue 09 15:25
OC4.2
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
Queen Mary University London, London, UK
Tue 09 15:40
OC4.3
[11C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism
University of Cambridge, Cambridge, UK
Tue 09 15:55
OC4.4
24-hour dynamics of free tissue adrenal hormones: A description of healthy normal variation
University of Bristol, Bristol, UK
Tue 09 16:10
OC4.5
Circulating cell-free DNA-based biomarkers as a tool for disease surveillance in adrenocortical carcinoma
Institute of Metabolism and System Research, Birmingham, UK
Tue 09 16:25
OC4.6
Glucocorticoids and the Vascular Molecular Clock : Implications in Vascular Function Control
Centre for Cardiovascular Science, Edinburgh, United Kingdom
Tue 09 15:10
OC5.1
Successful adeno-associated virus mediated neonatal gene therapy treatment of hypophosphatasia murine model resulted in bone maturation and increased survival to at least 18 months
Nippon Medical School, Tokyo, Japan
Tue 09 15:25
OC5.2
Gastric inhibitory polypeptide (GIP) reduces human osteoclast activity by suppressing multiple signalling pathways
Odense University Hospital, Odense, Denmark
Tue 09 15:40
OC5.3
Role of Intact and C-Terminal FGF-23 Assays in the Investigation of Metabolic Bone Disease.
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
Tue 09 16:10
OC5.5
Diacylglycerol kinase delta haploinsufficiency in mice causes hypocalcaemia: relevance to human Autosomal Dominant Hypoclacemia (ADH)
University of Oxford, Oxford, UK
Tue 09 16:25
OC5.6
The role of vitamin D supplementation in critically ill patients with COVID-19
Newcastle University, Newcastle, UK
Tue 09 15:10
OC6.1
Tue 09 15:25
OC6.2
Concerted action of TH transporters MCT8 and OATP1C1 regulates adult hippocampal neurogenesis and hippocampal function in mice
University of Duisburg-Essen, Essen, Germany
Tue 09 15:40
OC6.3
Failure of Radioiodine Remnant Ablation to Improve Postoperative Outcome in 2668 Adult Patients with AJCC/pTNM stage I Papillary Thyroid Carcinoma
Mayo Clinic, Rochester, MN, USA
Tue 09 15:55
OC6.4
AP-2 and Moesin Regulate the Internalisation of the Sodium-Iodide Symporter and Affect I125 Uptake in Thyroid Cancer Cells.
University of Birmingham, Birmingham, UK
Tue 09 16:10
OC6.5
Effects of in utero thyroid hormone exposure on human neurodevelopment: MRI analysis from the Controlled Antenatal Thyroid Screening Study
Cardiff University, Cardiff, UK
Tue 09 16:25
OC6.6
Forty years' experience of national screening programme for congenital hypothyroidism in Northern Ireland.
Queen's University Belfast, Belfast, UK
Royal Victoria Hospital, Belfast, UK
Wed 10 12:55
OP5.1
Parathyroid hormone (PTH) of 1.6 pmol/L or more at 6 months is associated with delayed recovery of parathyroid function in post-surgical hypoparathyroidism (PoSH)
University of Sheffield, Sheffield, UK
Wed 10 13:03
OP5.2
Society for Endocrinology / Parathyroid UK National Hypoparathyroidism Management Audit
Norfolk and Norwich University Hospital, Norwich, UK
Wed 10 13:11
OP5.3
Vitamin D deficiency is highly prevalent among patients who died from COVID-19 in the North-East of England.
University of Newcastle, Newcastle, UK
Wed 10 13:19
OP5.4
Normocalcaemic hyperparathyroidism: Impact of assay and reference range differences on the diagnosis
The Royal Wolverhampton NHS Trust, Wolverhampton, UK
Wed 10 13:30
OP6.1
Incidental findings are common, but rarely clinically significant, in patients with Neuroendocrine Tumours undergoing Gallium68 Dotatate PET CT; results from a one year retrospective review
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Wed 10 13:38
OP6.2
The evaluation of a musculoskeletal health package intervention to prevent bone toxicity in women with gynaecological malignancies undergoing pelvic radiotherapy. The RadBone randomised controlled feasibility study.
Christie Hospital NHS Foundation Trust, Manchester, UK
Wed 10 13:46
OP6.3
An unusual presentation of hypoglycaemia: An investigative challenge
Imperial College London, London, UK
Wed 10 13:54
OP6.4
Virtual Blood Pressure Monitoring in the Pre-operative Management of Phaeochromocytoma Patients in a Tertiary Centre during the COVID-19 Pandemic
The Christie NHS Foundation Trust, Manchester, UK
Tue 09 13:05
MTE3
Thyroid disease assessment and management; controversies in the NICE guidelines
University of Birmingham, Birmingham, UK
Tue 09 13:05
MTE7.1
Hydrocortisone pump - Innovative practice across both NHS and Independent sector
The London Clinic, London, UK
Tue 09 13:05
MTE7.2
How adolescent care is different to adults or children
Guy's and St. Thomas' NHS Foundation Trust, London, UK
Wed 10 12:10
MTE4
Thyroid surveillance after radiotherapy
Memorial Sloane Kettering Cancer center, New York, USA
Wed 10 12:10
MTE6
Primary interventions in obesity and weight management
University of Birmingham, Birmingham, UK
Mon 08 10:15
AN1
Discovery of a new hormone, leptin, and its roles in health and disease
Rockefeller University, New York, USA
Mon 08 14:00
PL1
Mon 08 14:30
PL2
Strategies to turn up the heat - investigating human brown adipose tissue function
University of Edinburgh, Edinburgh, UK
Tue 09 08:30
PL4
Feast and famine: nuclear receptor control of liver energy balance
University of California, California, USA
Tue 09 09:00
PL5
Activation of the gp130 receptor: a panacea for the treatment of metabolic diseases?
Monash University, Melbourne, Australia
Tue 09 18:45
PL6
Rethinking critical illness-induced corticosteroid insufficiency
Leuven University, Leuven, Belgium
Wed 10 16:10
PL9
Revisiting Cushing’s: The power of pre-receptor metabolism
University of Oxford, Oxford, UK
Wed 10 16:40
PL10
Cancer Treatment Endocrinopathies and growth hormone status throughout life
The Christie NHS Foundation Trust, Manchester, UK
Tue 09 11:30
NS1.1
Advances in the management of Acromegaly 2021
Green Templeton College, University of Oxford, London, UK
Tue 09 12:30
NS1.3
Addressing the unmet psychosocial needs of patients with treated Acromegaly
Association for Multiple Endocrine Neoplasia Disorders, Southborough, UK
Tue 09 15:30
NS2.2
Graduate Experience – Masters Module in Endocrine Nursing
University of Oxford Hospitals, Oxford, UK
Tue 09 16:15
NS2.4
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Tue 09 17:10
NS3.1
Management of Hyponatraemia and Diabetes Insipidus
University College London Hospital, London, UK
Tue 09 17:10
NS3.2
Management of adrenal insufficiency
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.3
Management of hyper- and hypo-thyroidism
University College London Hospital, London, UK
Tue 09 17:10
NS3.5
Management of calcium disorders and osteoporosis
University Hospitals Birmingham, Birmingham, UK
Mon 08 11:05
HDI1.1
How should I investigate for effect of radiotherapy on the hypothalamus and pituitary?
Unknown speaker
The Christie NHS Foundation Trust, Manchester, UK
Mon 08 11:20
HDI1.2
Mon 08 11:35
HDI1.3
Mon 08 11:50
HDI1.4
How do I screen an SDH gene carrier?
Unknown speaker
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Mon 08 12:05
HDI1.5
How do I keep my patients with adrenal insufficiency safe?
University College London Hospital, London, UK
Mon 08 12:20
HDI1.6
How do I optimise thyroid status after RAI therapy?
Royal Infirmary of Edinburgh, Edinburgh, UK
Tue 09 12:00
S2.2
Bile acid metabolism & nuclear receptors in male reproduction
GReD, Clermont-Ferrand, France
Tue 09 12:30
S2.3
Rapid gene therapy targeting of nuclear receptor pathways in the testis
University of Newcastle, New South Wales, Australia
Tue 09 11:30
S3.1
Diagnosis and management of MEN1 in childhood and adolescence
University of Oxford, Oxford, UK
Tue 09 12:00
S3.2
Advances in diagnostics for ACC-a multiomics approach
MRC Laboratory of Medical Sciences, London, UK
Tue 09 12:30
S3.3
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
Unknown speaker
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
Wed 10 11:35
S4.3
Translational Studies in Thyroid Hormone Transport
Erasmus Medical Center, Rotterdam, The Netherlands
Wed 10 10:35
S5.1
Osteomorphs: a newcell entity regulating bone resorption
Garvan Institute of Medical Research, Sydney, Australia
Wed 10 11:35
S5.3
Targeting the Calcium-Sensing Receptor
National Institute of Dental and Craniofacial Research, Bethesda MD, USA
Wed 10 10:35
S6.1
Single cell sequencing: lessons for the pathogenesis of adrenocortical tumours
Unknown speaker
University of Birmingham, Birmingham, United Kingdom
Wed 10 11:05
S6.2
Wed 10 11:35
S6.3
CT characteristics of adrenal nodules to guide management
Mayo Clinic, Minnesota, USA
Mon 08 09:45
WIN1
What is New in Basic Endocrinology Research?
Imperial College London, London, United Kingdom
Mon 08 10:00
WIN2
Mon 08 17:00
PR1
Elucidation of cellular oxygen sensing mechanisms: implications for medicine
Nuffield Department of Medicine, Oxford, UK
Tue 09 07:40
ARG1.1
Androgen replacement in men: Classification, diagnosis and biochemical assessment
Imperial College London, London, UK
Tue 09 08:00
ARG1.2
Changes to safety monitoring for androgen replacement in men
Imperial College London, London, UK
Tue 09 09:35
EC1.1
Early Career Prize Lecture Basic Science: Using gene discovery to identify new key regulators of beta cell development
University of Exeter, Exeter, UK
Tue 09 09:55
EC1.2
Early Career Prize Lecture Clinical: Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study
University of Birmingham, Birmingham, UK
Tue 09 10:15
EC1.3
CET Best Clinical Abstract: Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia
Diurnal Ltd, Cardiff, United Kingdom
Diurnal Ltd, Sheffield, UK
Tue 09 10:25
EC1.4
CET Best Basic Abstract: The vagal calcium sensing receptor mediates the effect of protein ingestion on insulin release and regulates macronutrient metabolism
Imperial College London, London, UK
Tue 09 11:00
TAA1
Teaching fertile minds- seeking out teaching opportunities during clinical training
Imperial College London, London, UK
Tue 09 11:15
TAA2
Tue 09 11:00
OCP1.1
Improving the care of patients with thyroid diseases
St Bartholomew’s Hospital, London, UK
Tue 09 11:15
OCP1.2
Patient safety - Shifting the paradigm
University College London Hospital, London, UK
Tue 09 11:15
NKM1
Nikki Kieffer Medal
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Tue 09 12:30
S1.3
A new era in gut-hormone based pharmacotherapy for people with obesity?
University College London, London, UK
Tue 09 17:10
HDI2.1
How do I investigate abnormal alkaline phosphatase and bone context?
St Vincent's University Hospital, Dublin, Ireland
Tue 09 17:25
HDI2.2
How do I diagnose and manage a low testosterone in men with obesity?
Imperial College London, London, UK
Tue 09 17:40
HDI2.3
How do I manage pituitary macroadenoma in pregnancy?
The University of Edinburgh, Edinburgh, UK
Tue 09 17:55
HDI2.4
How do I screen for cardiovascular effects of cancer treatments?
University College London Hospital, London, UK
Tue 09 18:10
HDI2.5
How do I confirm biochemical diagnosis of primary aldosteronism?
Queen Elizabeth University Hospital, Glasgow, UK
Tue 09 18:25
HDI2.6
How do I approach isolated hypothyroxinaemia?
Beacon Hospital and University College Dublin, Dublin, Ireland
Tue 09 17:40
SE1.2
What in the World is EIS?
National Institute of Environmental Health Sciences, Durham, USA
Tue 09 18:10
SE1.3
INSL3: a new index of testis function in puberty and aging
University of Nottingham, Nottingham , UK
Wed 10 09:35
FOE1.1
Wed 10 09:40
FOE1.2
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:00
FOE1.4
The Society for Endocrinology Resource Hub
Homerton University Hospital, London, UK
Wed 10 10:10
FOE1.5
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Unknown speaker
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Wed 10 09:35
SK1.1
The Geneticist's Perspective
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Wed 10 14:10
Updates and future plans for the Bone and Calcium network
Norfolk and Norwich University Hospital, Norfolk, UK
University of Birmingham, Birmingham, UK
Wed 10 14:10
Hormones, Cancer and COVID - headlines from 2020-21
Imperial College London, London, UK
Wed 10 14:10
A survey on the management of metastatic PPGL in UK & Ireland
Unknown speaker
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Wed 10 14:10
What skills, techniques and experience can you gain from visiting another laboratory
Coventry University, Coventry, UK
Wed 10 14:15
How to follow-up a patient with with Cushing's and remission after surgery
University of Sheffield, Sheffield, UK
Wed 10 14:10
An overview of thyroid papers
University of Edinburgh, Edinburgh, UK
Unknown speaker
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Wed 10 14:20
Summary of the NIHR assessment of RFA in thyroid nodules
University of Birmingham, Birmingham, UK
Wed 10 15:05
ECS1.2
Post-doc to Research Facilitator; making the transition
University of Birmingham, Birmingham, UK
Wed 10 15:20
Influencing at scale: NHS leadership and shaping policy
University Hospitals Birmingham, Birmingham, UK
Wed 10 15:50
Wed 10 15:40
Blood doping: climbing to the peak of athletic performance
Oslo University Hospital, Oslo, Norway
0 result(s) found.